Pharmaceuticals Europe

Europe Malaria Vaccines Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Europe Malaria Vaccines Market Industry Trends and Forecast to 2034: Segmented by (Product, Region, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $50.6 Mn Placeholder estimate
Estimate 2025 $62.7 Mn 20.1% of the global market
Projected 2034 $428.2 Mn 583.1% Adds $365.5 Mn over 9 forecast years
CAGR 2025–2034 23.8% Faster than 93% of 180 Pharmaceuticals markets here
Key players 5
  • Europe is 20.06% of the global market.
  • Among regions, the largest is North America at $166.5 Mn.
  • Fastest growing: APAC at 26.5% a year.
  • Europe ranks 3rd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$365.5 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Malaria Vaccines Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $50.6 Mn — —
2025 (base) $62.7 Mn +$12.1 Mn —
2026 (forecast) $77.6 Mn +$14.9 Mn +23.8%
2027 (forecast) $96.1 Mn +$18.5 Mn +53.3%
2028 (forecast) $118.9 Mn +$22.9 Mn +89.7%
2029 (forecast) $147.2 Mn +$28.3 Mn +134.9%
2030 (forecast) $182.3 Mn +$35.0 Mn +190.8%
2031 (forecast) $225.7 Mn +$43.4 Mn +260%
2032 (forecast) $279.4 Mn +$53.7 Mn +345.7%
2033 (forecast) $345.9 Mn +$66.5 Mn +451.8%
2034 (forecast) $428.2 Mn +$82.3 Mn +583.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Malaria Vaccines Market Analysis at a glance
Market size, 2025$62.7 Mn placeholder estimate
Forecast, 2034$428.2 Mn placeholder estimate
Growth (CAGR), 2025–203423.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, region and end user (see all)
Key playersGSK PLC, Serum Institute of India, Bharat Biotech, Sanaria, BioNTech (see all)
Regulator in EuropeEMASource: European Medicines Agency. Checked 14 Nov 2026.
Active clinical trials3 in EuropeSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Malaria Vaccines Market Analysis Executive Summary

Malaria vaccines protect young children in high-risk areas against malaria, a leading cause of child deaths in Africa.

Key segments of the malaria Vaccines market include product (RTS,S/AS01, R21/Matrix-M and Candidates) and region (Sub-Saharan Africa, Asia and Latin America).

Bar chart: Europe Malaria Vaccines market size, 2024–2034, placeholder estimates. $50.6 Mn in 2024, $62.7 Mn in 2025 and $428.2 Mn in 2034, 23.8% CAGR.
Europe Malaria Vaccines market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Malaria Vaccines Market Dynamics

Market Growth Drivers

Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the malaria Vaccines market.

Opportunity

New vaccines, rapid tests and public-private funding for neglected diseases give the malaria Vaccines market room to grow, especially in Asia, Africa and Latin America.

Market Restraints

Low prices in poorer markets, weak returns for new antibiotics, vaccine hesitancy and cold-chain problems hold back the malaria Vaccines market.

Competitive Landscape for Malaria Vaccines Market in Europe

The malaria Vaccines market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Malaria Vaccines Market in Europe

Malaria Vaccines in Europe: rules, payment and research

In the EU, many new medicines are authorised once for every member state by the European Commission, after review by the European Medicines Agency (EMA).⁠[1] In the countries we cover here, medicines are approved by ANSM (France)⁠[2], BfArM (Germany)⁠[3], AIFA (Italy)⁠[4], Ministry of Health (Russia)⁠[5], AEMPS (Spain)⁠[6] and MHRA (UK)⁠[7]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.⁠[8] ClinicalTrials.gov lists 3 studies on Malaria Vaccines that are recruiting, active or about to start in Europe.⁠[9]

[1] European Medicines Agency. Checked 14 Nov 2026.

[2] ANSM, French medicines agency. Checked 14 Nov 2026.

[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.

[4] Italian Medicines Agency (AIFA). Checked 14 Nov 2026.

[5] Ministry of Health of the Russian Federation. Checked 14 Nov 2026.

[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.

[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.

[8] European Commission, health technology assessment. Checked 14 Nov 2026.

[9] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for malaria Vaccines. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Europe.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Malaria Vaccines right now, from free public sources.

Clinical trials

3 active trials in UK, Germany, France, Italy, Spain and Russia

Recruiting, about to start, or running now. Counted across the 6 countries we report on in Europe.

Top trial sponsors (worldwide)

  1. Sanaria 4 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Malaria Vaccines in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Malaria Vaccines market in Europe?
Placeholder estimate: about $62.7 Mn in 2025, rising to about $428.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Malaria Vaccines market in Europe growing?
Placeholder estimate: about 23.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Malaria Vaccines market report cover?
The report splits the market by product (RTS,S/AS01, R21/Matrix-M, Candidates), region (Sub-Saharan Africa, Asia, Latin America) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Malaria Vaccines market?
Key players include GSK PLC, Serum Institute of India, Bharat Biotech, Sanaria and BioNTech.
What is driving the Malaria Vaccines market?
Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the malaria Vaccines market.
Who regulates Malaria Vaccines in Europe?
In the EU, many new medicines are authorised once for every member state by the European Commission, after review by the European Medicines Agency (EMA). Source: European Medicines Agency. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How many clinical trials on Malaria Vaccines are running in Europe?
3 studies are recruiting, active or about to start in Europe, counted across the 6 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
How much research is published on Malaria Vaccines?
PubMed lists 325 papers on Malaria Vaccines added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Europe

See all

Related on vaccines and malaria

See the topic